Skip Navigation


Journal of the National Cancer Institute Advance Access originally published online on October 30, 2007
JNCI Journal of the National Cancer Institute 2007 99(21):1644-1645; doi:10.1093/jnci/djm177
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
99/21/1644-a    most recent
djm177v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Veronesi, U.
Right arrow Articles by Decensi, A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Veronesi, U.
Right arrow Articles by Decensi, A.
Related Collections
Right arrowCorrespondence about this Article
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press.

CORRESPONDENCE

Responses: Re: Treatment of Human Epidermal Growth Factor Receptor 2-Overexpressing Breast Cancer Xenografts With Multiagent Human Epidermal Growth Factor Receptor-Targeted Therapy

Umberto Veronesi, Bernardo Bonanni, Andrea Decensi

Affiliations of authors: European Institute of Oncology, Milan, Italy (UV, BB); Ospedale Galliera, Genoa, Italy (AD)

Correspondence to: Umberto Veronesi, MD, European Institute of Oncology, via Ripamonti 435, Milan, Italy (e-mail: umberto.veronesi@ieo.it).

The first 10% of the full text of this article appears below.

Ferretti et al. comment on our recent article on the late results of the Italian Tamoxifen Prevention Trial (1). They discuss the mixed findings of the effects of tamoxifen in users of hormone replacement therapy . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Correspondence about this Article

Re: Treatment of Human Epidermal Growth Factor Receptor 2–Overexpressing Breast Cancer Xenografts With Multiagent Human Epidermal Growth Factor Receptor–Targeted Therapy
Gianluigi Ferretti, Alessandra Felici, and Francesco Cognetti
J Natl Cancer Inst 2007 99: 1644. [Extract] [Full Text] [PDF]